{"role": "assistant", "content": null, "function_call": {"name": "get_risks", "arguments": "{\"risks\":[{\"Description\":\"Use of drugs in treatment of SARS-CoV-2 infection\",\"Impact\":\"Potential adverse effects or drug interactions\",\"Mitigation\":\"Careful monitoring and evaluation of patient response\",\"Technologies\":\"Pharmacovigilance systems\",\"People\":\"Patients receiving treatment for SARS-CoV-2 infection\",\"Owner\":\"Healthcare providers and medical professionals\"},{\"Description\":\"Off-label use of favipiravir for SARS-CoV-2 treatment\",\"Impact\":\"Undefined safety and efficacy for SARS-CoV-2\",\"Mitigation\":\"Clinical trials and research to establish safety and efficacy\",\"Technologies\":\"Clinical trial research and data analysis tools\",\"People\":\"Healthcare providers, researchers, and patients\",\"Owner\":\"Pharmaceutical companies, regulatory agencies\"}]}"}}